ESMO 2017 highlights on managing difficult to treat cancers

ESMO 2017 roundup with Dr Bishal Gyawali (1/2)

ESMO 2017 roundup with Dr Bishal Gyawali (2/2)

Initial results of inhibitor combination against breast and gynaecologic cancers

LORELEI trial of letrozole and taselisib for ER positive breast cancer

Nivolumab and ipilimumab for metastatic kidney cancer

Checkmate 238: Adjuvant checkpoint therapy after melanoma resection

The METRIC trial of trametinib, five years on

Treatment choices in thyroid cancer

Clinical advances in treating colorectal cancer

RANGE trial of ramucirumab for urothelial cancer

Small node-negative breast cancers may retain aggressive characteristics